NF-κB: a therapeutic target in inflammatory diseases

Bibliography

• KARIN M, BEN-NERIAH Y: Phosphorylation meets ubiquitination: the control of NF-KB activity. Ann. Rev. Immunol (2000) 18:621–663.
   PubMed Web of Science ®Google Scholar
• •A good review of the multiple factors involved in the regula-tion of NF-KB activity.
   Google Scholar
• SEN R, BALTIMORE D: Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell (1986) 46:705–716.
   PubMed Web of Science ®Google Scholar
• SHA WC: Regulation of immune responses by NF-KB/ Rel transcription factors. J. Exp. Med. (1998) 187 (2):143–146.
   PubMed Web of Science ®Google Scholar
• KUNSCH C, RUBEN SM, ROSEN CA: Selection of optimal kappa B/ Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation. MM. Cell Biol. (1992) 12:4412–4421.
   Web of Science ®Google Scholar
• GORLICH D, MATTAJ IW: Nucleocytoplasmic transport. Science (1996) 271:1513–1518.
   PubMed Web of Science ®Google Scholar
• KARIN M, DELHASE M: The IKB kinase (IKK) and NF-KB: key elements of proinflammatory signaling. Semin. Immunol (2000) 12:85–98.
   PubMed Web of Science ®Google Scholar
• ••Excellent review of the IKK complex.
   Google Scholar
• DELHASE M, HAYAKAWA M, CHENY, KARIN M: Positive and negative regulation of IKBkinase activity through IMO subunit phosphorylation. Science (1999) 284:309–313.
   PubMed Web of Science ®Google Scholar
• KARIN M: The beginning of the end: I1(13 kinase (IKK) and NF-KB activation. J. Biol. Chem. (1 9 9 9) 274 (39):27339–27342.
   Google Scholar
• ROTHVVARF DM, ZANDI E, NATOLI G, KARIN M: IKK-7 is an essential regulatory subunit of the IKB kinase complex. Nature (1998) 395:297–300.
   PubMed Web of Science ®Google Scholar
• PAHL HL: Activators and target genes of Rel/ NF-KB transcription factors. Oncogene (1999) 18:6853–6866.
   PubMed Web of Science ®Google Scholar
• •Includes exhaustive list of NF-KB activators and target genes.
   Google Scholar
• SCHWARTZ MD, MOORE EE, MOORE FA et al.: Nuclear-factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Grit. Care Med. (1996) 24:1285–1292.
   PubMed Web of Science ®Google Scholar
• MOINE P, McINTYRE R, SCWARTZ MD et al.: NF-kappa B regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome. Shock (2000) 1 3:85–91.
   Google Scholar
• CHRISTMAN JW, VENKATAKRISHNAN A, WHEELER AP, BERNARD GR, BLACKWELL TS: NF-KB binding activity in mixed BAL cells from patients with SIRS and ARDS. Sepsis (2000) 4:35–41.
   Google Scholar
• BOHRER H, QIU F, ZIMMERMANN T et al.: Role of NF-KB in the mortality of sepsis. J. Clin. Invest. (1997) 100:972–985.
   PubMed Web of Science ®Google Scholar
• PATERSON RL, GALLEY HF, DHILLON JK, WEBSTER NR:Increased nuclear factor kappa B activation in critically ill patients who die. Grit. Care Med. (2000) 28:1047–1051.
   PubMed Web of Science ®Google Scholar
• ARNALICH F, GARCIA-PALOMERO E, LOPEZ J et al:Predictive value of nuclear factor kappa B activity and plasma cytokine levels in patients with sepsis. Infect. Immun. (2000) 68:1942–1945.
   PubMed Web of Science ®Google Scholar
• ADIB-CONQUY M, ADRIE C, MOINE P et al: NF-KB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. Am. J. Respr. Crit. Care Med. (2000) 162:1877–1883.
   Web of Science ®Google Scholar
• SCHREIBER S, NIKOLAUS S, HAMPE J: Activation of nuclear factor KB in inflammatory bowel disease. Gut (1998) 42:477–484.
   PubMed Web of Science ®Google Scholar
• NEURATH MF, FUSS I, SCHURMANN G et al: Cytokine gene transcription by NE-KB family members in patients with inflammatory bowel disease. Ann. NY Acad. Sci. (1998) 859:149–159.
   PubMed Web of Science ®Google Scholar
• CAMPBELL IK, GERONDAKIS S, O'DONNELL K, WICKS IP: Distinct roles for the NF-IcB1 (p50) and c-Rel transcrip-tion factors in inflammatory arthritis. J Clin. Invest. (2000) 105:1799–1806.
   PubMed Web of Science ®Google Scholar
• BONDESON J, FOXVVELL B, BRENNAN F, FELDMANN M: Defining therapeutic targets by using adenovirus: blocking NE-KB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. Proc. Natl. Acad. Sci. (1999) 96:5668–5673.
   PubMed Web of Science ®Google Scholar
• EPINAT JC, GILMORE TD: Diverse agents act at multiple levels to inhibit the Rel/ NF-IcB signal transduction pathway. Oncogene (1999) 1 8 (49) :6896–6909.
   Google Scholar
• ••Good, comprehensive review of inhibitors of NF-icB. Theentire issue of this journal is dedicated to the subject of NF-KB.
   Google Scholar
• SCHRECK RK, ALBERMAN K, BAEUERLE PA: Nuclear factor KB: an oxidative stress-response transcription factor of eukaryotic cells. Free Radic. Res. Commun. (1992) 17:221–237.
   PubMed Web of Science ®Google Scholar
• MIROCHINITCHENKO O, INOUYE M: Effect of overex-pression of human Cu, Zn superoxide dismutase in transgenic mice on macrophage functions. j immunoi. (1996) 156:1578–86.
   PubMed Web of Science ®Google Scholar
• KONO H, RUSYN I, YIN M et al.: NADPH oxidase-derivedfree radicals are key oxidants in alcohol-induced liver disease. J. Clin. Invest. (2000) 106(7):867–872.
   PubMed Web of Science ®Google Scholar
• KOVACICH JC, BOYLE EM, MORGAN EN et al.: Inhibitionof the transcriptional activator protein nuclear factor [kappa] B prevents hemodynamic stability associated with whole- body inflammatory response syndrome. J. Thorac. Cardiovasc. Surg. (1999) 118:154–162.
   PubMed Web of Science ®Google Scholar
• LAUZURICA P, MARTINEZ-MARTINEZ S, MARAZUELA M etPyrrolidine dithiocarbamate protects mice from lethal shock induced by LPS or TNF-a. Eur. J. Immunol. (1999) 29:1890–1900.
   PubMed Web of Science ®Google Scholar
• ROSS SD, KRON IL, GANGEMI JJ et al: Attenuation oflung reperfusion injury after transplantation using an inhibitor of nuclear-factor kappaB. Am. J. Physiol. Lung Cell Mol. Physiol. (2000) 279(3):L528–536.
   PubMed Web of Science ®Google Scholar
• BLACKWELL TS, HOLDEN EP, BLACKWELL TR, CHRISTMAN BW, CHRISTMAN JW: Activation of NE-KB in rat lungs by treatment with endotoxin: modulation by treatment with N-acetylcysteine. j immunoi. (1996) 157:1630–1637.
   PubMed Web of Science ®Google Scholar
• BERNARD GR, WHEELER AP, ARONS MM et al.: A trial ofanti-oxidants N-acetylcysteine and procysteine in ARDS. Chest (1997) 112:164–172.
   PubMed Web of Science ®Google Scholar
• BOWIE A, O'NEIL LAJ: Oxidative Stress and nuclearfactor-KB activation. Areassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. (2000) 59:13–23.
   PubMedGoogle Scholar
• SCHENMAN RI, COGSWELL PC, LOFQUIST AK, BALDWINAS: Role of transcriptional activation of 'KW( in mediation of immunosuppression by glucocorticoids. Science 270:283–286.
   Google Scholar
• AUPHAN N, DIDONATO JA, ROSETTE C, HELMBERG A,KARIN M: Immunosuppression by glucocorticoids: inhibition of NE-KB activity through induction of IKB synthesis. (1995) Science 270:286–290.
   Google Scholar
• DE BOSSCHER K, SCHMITZ ML, BERGHE WV, PLAISANCES, FIERS W, HAEGEMAN G: Glucocorticoid-mediated repression of nuclear factor-KB-dependant transcrip-tion involves direct interference with transactivation. Proc. Nati Acad. Sci. (1997) 94:13504–13509.
   PubMed Web of Science ®Google Scholar
• RAY A, PREFONTAINE KE: Physical association andfunctional antagonism between the p65 subunit of transcription factor NE-KB and the glucocorticoid receptor. Proc. Natl. Acad. Sci. (1994) 91:752–756.
   PubMed Web of Science ®Google Scholar
• HADDAD EB, SALMON M, KOTO H, BARNES PJ, ADCOCKI, CHUNG KF: Ozone induction of cytokine-induced neutrophil chemoattractant (CINC) and nuclear factor Kb in rat lung: inhibition by corticosteroids. FEBS lett. (1996) 379:265–268.
   PubMed Web of Science ®Google Scholar
• SADIKOT R, JANSEN ED, BLACKWELL T et al.: High dosedexamethasone accentuates NE-KB activation in endotoxin-treated mice. (In Press).
   Google Scholar
• UN Y, BROWN K, SIEBENLIST U: Activation of NF-KBrequires proteolysis of the inhibitor IKBa: signal induced phosphorylation of IKBa alone does not release active NF-KB. Proc. Natl. Acad. Sci. (1995) 92:552–556.
   PubMed Web of Science ®Google Scholar
• RUETTEN H, THIEMERMANN C: Effect of calpaininhibitor I, an inhibitor of the proteolysis of IKB, on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat. Br. J. Pharmacol. (1997) 121:695–704.
   PubMed Web of Science ®Google Scholar
• CUZZOCREA S, MCDONALD M, MAZZON E et al.: Calpaininhibitor I reduces the development of acute and chronic inflammation. Am. J. Pathol. (2000) 157:2065–2079.
   PubMed Web of Science ®Google Scholar
• LANCASTER LH, CHRISTMAN JW, BLACKWELL TR, KOAY MA, BLACKWELL TS: Suppression of lung inflammation in rats by prevention of NE-KB activation in the liver. Inflamm. (In press)
   Google Scholar
• KOPP E, GHOSH S: Inhibition of NE-KB by sodium salicylate and aspirin. Science (1994) 265:956–959.
   PubMed Web of Science ®Google Scholar
• YIN M, YAMAMOTO Y, GAYNOR RB: The anti-inflammatory agents aspirin and salicylate inhibit the activity of IKB kinase-I3. Nature (1998) 396:77–80.
   PubMed Web of Science ®Google Scholar
• FRANTZ B, O'NEIL1 EA: The effect of sodium salicylate and aspirin on NE-KB. Science (1995) 270: 2017-2018.
   Google Scholar
• CASTRILLO A, DIAZ-GUERRA MJM, HORTELANO S, MARTIN- SANZ P, BOSCA L: Inhibition of IKBkinase and IKB phosphorylation by 15-Deoxy-412, 14-prostaglandin j2 in activated murine macrophages. Mol. Cell Biol. (2000) 20:1692–1698.
   PubMed Web of Science ®Google Scholar
• ROSSI A, KAPAHL O, NATOLL G et al: Anti-inflammatory cyclopentanone prostaglandins are direct inhibitors of I kappa B kinase. Nature (2000) 403:103–108.
   PubMed Web of Science ®Google Scholar
• STRAUS DS, PASCUAL G, LI M et al.: 15-Deoxy-412, 14-prostaglandin j2 in inhibits multiple steps in the NE-KB signaling pathway. Proc. Natl. Acad. ScL (2000) 97:4844–4849.
   PubMed Web of Science ®Google Scholar
• HORTELANO S, CASTRILLO A, ALVAREZ AM, BOSCA L:Contribution of cyclopentanoneprostaglandins to the resolution of inflammation through potentiation of apoptosis in activated macrophages. J Immunol (2000) 165:6525–6531.
   PubMed Web of Science ®Google Scholar
• BROCKMAN JA, SCHERER DC, MCKINSEY TA et al.: Coupling of signal response domain in IKBa to multiple pathways for NE-KB activation. Mol. Cell Biol. (1995) 15:2809–2818.
   PubMed Web of Science ®Google Scholar
• BALDI L, BROWN K, FRANZOSO G, SIEBENLIST U: Critical role for Lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of IKBa. J Biol. Chem. (1996) 271:376–379.
   PubMed Web of Science ®Google Scholar
• LING L, CAO Z, GOEDDEL DV: NE-KB-inducing kinase activates IKK-a by phosphorylation of Ser-176. Proc. Natl. Acad. Sci. (1998) 95:3792–3797.
   PubMed Web of Science ®Google Scholar
• O'CONNELL MA, BENNETT BL, MERCURIO F, MANNING AM, MACKMAN N: Role of IKK1 and IKK2 in lipopoly-saccharide signaling in human monocytic cells. J. Biol. Chem. (1998) 273:30410–30414.
   PubMed Web of Science ®Google Scholar
• LIN Y, YAO S, VEACH RA, TORGERSON TR, HAWIGER J: Inhibition of nuclear translocation of transcription factor NE-KB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. (1995) 270(2014255–144258.
   Web of Science ®Google Scholar
• LIU X, ROBINSON D, VEACH RA et al.: Peptide-directed suppression of a pro-inflammatory cytokine response. J. Biol. Chem. (2000) 275(22):16774–16778.
   PubMed Web of Science ®Google Scholar
• FUJIHARA S, CLEAVELAND J, GROSMAIRE L et al.: A D-amino acid peptide inhibitor of NE-KB nuclear localization is efficacious in models of inflammatory disease. J. Immunol. (2000) 165:1004–1012.
   PubMed Web of Science ®Google Scholar
• MAY MJ, D'ACQUISTO F, MADGE LA et al.: Selective inhibition of NE-KB activation by a peptide that blocks the interaction of NEMO with the IKBkinase complex. Science (2000) 289:1550–1554.
   Google Scholar